Literature DB >> 22414497

Virulence of Streptococcus pneumoniae serotype 6C in experimental otitis media.

Vishakha Sabharwal1, Marisol Figueira, Stephen I Pelton, Melinda M Pettigrew.   

Abstract

Increases in colonization with serotypes of Streptococcus pneumoniae not contained within the 7-valent pneumococcal conjugate vaccine (PCV) have been reported among children following introduction. Serotype 6C has emerged as prevalent in nasopharyngeal colonization and acute otitis media (AOM), though it is uncommonly recovered from children with invasive pneumococcal disease. Vaccine serotypes within PCV7 have been replaced by nonvaccine serotypes without significant changes in the overall carriage rate. We hypothesize 1) that serotypes vary in their ability to evade host defenses and establish AOM following colonization and 2) the observed reduction in pneumococcal otitis results from a reduced disease potential by some 'replacement serotypes'. We compared the capacity of S. pneumoniae serotypes 6C and 19A to produce experimental otitis media (EOM) in a chinchilla model. The proportion of chinchillas that developed culture positive EOM and density of middle ear infection was evaluated. EOM was found in 28/82 (34%) ears challenged with 6C compared to 13/18(72.2%) with 19A [p = 0.0003]. When disease due to 6C did occur, it was characterized by low-density infection. Our findings demonstrate that challenge with serotype 6C results in EOM less frequently than 19A. These data support the need for greater knowledge regarding differences among serotypes to produce AOM.
Copyright © 2012 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22414497      PMCID: PMC3382049          DOI: 10.1016/j.micinf.2012.02.008

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  45 in total

1.  Pre- and post-conjugate vaccine epidemiology of pneumococcal serotype 6C invasive disease and carriage within Navajo and White Mountain Apache communities.

Authors:  Eugene V Millar; Fabiana C Pimenta; Alexis Roundtree; Delois Jackson; Maria da Gloria Carvalho; Mindy J Perilla; Raymond Reid; Mathuram Santosham; Cynthia G Whitney; Bernard W Beall; Katherine L O'Brien
Journal:  Clin Infect Dis       Date:  2010-10-29       Impact factor: 9.079

2.  Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway.

Authors:  Didrik F Vestrheim; E Arne Høiby; Ingeborg S Aaberge; Dominique A Caugant
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

3.  Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains.

Authors:  Elske J M van Gils; Reinier H Veenhoven; Eelko Hak; Gerwin D Rodenburg; Wendy C M Keijzers; Debby Bogaert; Krzysztof Trzcinski; Jacob P Bruin; Loek van Alphen; Arie van der Ende; Elisabeth A M Sanders
Journal:  JAMA       Date:  2010-09-08       Impact factor: 56.272

4.  Requirement for capsule in colonization by Streptococcus pneumoniae.

Authors:  A D Magee; J Yother
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

5.  Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media.

Authors:  Valérie Bouchet; Derek W Hood; Jianjun Li; Jean-Robert Brisson; Gaynor A Randle; Adèle Martin; Zhong Li; Richard Goldstein; Elke K H Schweda; Stephen I Pelton; James C Richards; E Richard Moxon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-10       Impact factor: 11.205

6.  Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease.

Authors:  Inci Yildirim; William P Hanage; Marc Lipsitch; Kimberly M Shea; Abbie Stevenson; Jonathan Finkelstein; Susan S Huang; Grace M Lee; Ken Kleinman; S I Pelton
Journal:  Vaccine       Date:  2010-10-26       Impact factor: 3.641

7.  Experimental acute otitis media due to nontypeable Haemophilus influenzae: comparison of high and low azithromycin doses with placebo.

Authors:  Franz E Babl; Stephen I Pelton; Zhong Li
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

8.  Streptococcus pneumoniae clonal complex 199: genetic diversity and tissue-specific virulence.

Authors:  Jonathan C Thomas; Marisol Figueira; Kristopher P Fennie; Alison S Laufer; Yong Kong; Michael E Pichichero; Stephen I Pelton; Melinda M Pettigrew
Journal:  PLoS One       Date:  2011-04-14       Impact factor: 3.240

9.  Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae.

Authors:  S Ram; M Cullinane; A M Blom; S Gulati; D P McQuillen; B G Monks; C O'Connell; R Boden; C Elkins; M K Pangburn; B Dahlbäck; P A Rice
Journal:  J Exp Med       Date:  2001-02-05       Impact factor: 14.307

10.  Capacity of serotype 19A and 15B/C Streptococcus pneumoniae isolates for experimental otitis media: Implications for the conjugate vaccine.

Authors:  Alison S Laufer; Jonathan C Thomas; Marisol Figueira; Janneane F Gent; Stephen I Pelton; Melinda M Pettigrew
Journal:  Vaccine       Date:  2010-01-10       Impact factor: 3.641

View more
  4 in total

1.  Heparin binding-epidermal growth factor-like growth factor for the regeneration of chronic tympanic membrane perforations in mice.

Authors:  Peter Luke Santa Maria; Sungwoo Kim; Yasin Kursad Varsak; Yunzhi Peter Yang
Journal:  Tissue Eng Part A       Date:  2015-03-17       Impact factor: 3.845

Review 2.  Panel 4: Report of the Microbiology Panel.

Authors:  Stephen J Barenkamp; Tasnee Chonmaitree; Anders P Hakansson; Terho Heikkinen; Samantha King; Johanna Nokso-Koivisto; Laura A Novotny; Janak A Patel; Melinda Pettigrew; W Edward Swords
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04       Impact factor: 3.497

3.  Treatment of Streptococcus pneumoniae otitis media in a chinchilla model by transtympanic delivery of antibiotics.

Authors:  Rong Yang; Vishakha Sabharwal; Nadya Shlykova; Obiajulu S Okonkwo; Stephen I Pelton; Daniel S Kohane
Journal:  JCI Insight       Date:  2018-10-04

4.  Variation of pneumococcal Pilus-1 expression results in vaccine escape during Experimental Otitis Media [EOM].

Authors:  Marisol Figueira; Monica Moschioni; Gabriella De Angelis; Michèle Barocchi; Vishakha Sabharwal; Vega Masignani; Stephen I Pelton
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.